Division of Endocrinology/Diabetes Amanda House — Buffalo, New York

Division of Endocrinology/Diabetes Amanda House is a clinical research site located in Buffalo, New York, United States 14203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Division of Endocrinology/Diabetes Amanda House has participated in 1 clinical trials.

Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Sponsors: Rhythm Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Division of Endocrinology/Diabetes Amanda House?

Division of Endocrinology/Diabetes Amanda House has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Division of Endocrinology/Diabetes Amanda House conducted?

Division of Endocrinology/Diabetes Amanda House has 1 clinical trials on record. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Is Division of Endocrinology/Diabetes Amanda House accredited by Crixeo Health?

Division of Endocrinology/Diabetes Amanda House has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Division of Endocrinology/Diabetes Amanda House?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.